Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation

Affiliations

• ¹ Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ² Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
• ³ Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ⁴ Department of Pediatric Hematology/Oncology, Loma Linda University, Loma Linda, California, USA.